Detalles de la búsqueda
1.
Treatment persistence among patients with immune-mediated rheumatic disease newly treated with subcutaneous TNF-alpha inhibitors and costs associated with non-persistence.
Rheumatol Int
; 36(7): 987-95, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26780533
2.
Suboptimal persistence with inhaled corticosteroid monotherapy among children with persistent asthma in the UK.
Prim Care Respir J
; 20(1): 97-101, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20936252
3.
The effects of isolated versus multiple lipid disorders on resource utilization among metabolic syndrome patients with lipid abnormalities despite Lipid-modifying treatment.
Cardiology
; 117(2): 96-104, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20938176
4.
Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA).
BMC Public Health
; 10: 737, 2010 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-21114824
5.
Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review.
Eur J Cardiovasc Prev Rehabil
; 16(4): 404-23, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19465856
6.
Rates of asthma attacks in patients with previously inadequately controlled mild asthma treated in clinical practice with combination drug therapy: an exploratory post-hoc analysis.
BMC Pulm Med
; 9: 10, 2009 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19331689
7.
Effect of allergic rhinitis on the use and cost of health services by children with asthma.
Yonsei Med J
; 49(4): 521-9, 2008 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-18729293
8.
Low-density lipoprotein cholesterol in a global cohort of 57,885 statin-treated patients.
Atherosclerosis
; 255: 200-209, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27667299
9.
Contemporary data on low-density lipoprotein cholesterol target value attainment and distance to target in a cohort of 57,885 statin-treated patients by country and region across the world.
Data Brief
; 9: 616-620, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27766290
10.
Reasons for not initiating osteoporosis therapy among a managed care population.
Patient Prefer Adherence
; 9: 821-30, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26150702
11.
History of cardiovascular events and cardiovascular risk factors among patients initiating strontium ranelate for treatment of osteoporosis.
Int J Womens Health
; 7: 913-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26604831
12.
Attainment of normal lipid levels among high cardiovascular risk patients: pooled analysis of observational studies from the United Kingdom, Sweden, Spain and Canada.
Eur J Intern Med
; 24(7): 656-63, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23953848
13.
Mixed dyslipidemias in primary care patients in France.
Vasc Health Risk Manag
; 8: 247-54, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22566746
14.
Attainment of normal lipid levels among patients on lipid-modifying therapy in Hong Kong.
Adv Ther
; 29(5): 427-41, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22562782
15.
Persistent lipid abnormalities in statin-treated patients and predictors of LDL-cholesterol goal achievement in clinical practice in Europe and Canada.
Eur J Prev Cardiol
; 19(2): 221-30, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450578
16.
Association between extended-release niacin treatment and glycemic control in patients with type 2 diabetes mellitus: analysis of an administrative-claims database.
Metabolism
; 60(7): 1038-44, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21185576
17.
Association between dyslipidemia and vascular events in patients treated with statins: report from the UK General Practice Research Database.
Atherosclerosis
; 208(1): 210-6, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19766999
18.
Utilization patterns of extended-release niacin in Canada: analysis of an administrative claims database.
Can J Cardiol
; 26(7): e229-35, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20847969
19.
Impact of worsening renal function during hospital admission on resource utilization in patients with heart failure.
Am J Cardiol
; 106(8): 1139-45, 2010 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20920654
20.
Frequency of obtaining national cholesterol education program adult treatment panel III goals for all major serum lipoproteins after initiation of lipid altering therapy.
Am J Cardiol
; 104(12): 1689-94, 2009 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19962476